| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033269562 |
| P356 | DOI | 10.1038/NG.2504 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ng.2504 |
| P932 | PMC publication ID | 3826950 |
| P698 | PubMed publication ID | 23263488 |
| P5875 | ResearchGate publication ID | 233976574 |
| P50 | author | Barbara E. Stranger | Q30347493 |
| Gosia Trynka | Q30501374 | ||
| Buhm Han | Q88645519 | ||
| P2093 | author name string | X Shirley Liu | |
| Han Xu | |||
| Cynthia Sandor | |||
| Soumya Raychaudhuri | |||
| P2860 | cites work | A user's guide to the encyclopedia of DNA elements (ENCODE) | Q21092716 |
| Model-based analysis of ChIP-Seq (MACS) | Q21183902 | ||
| Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS | Q21563317 | ||
| Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 | ||
| Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis | Q24609915 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| Biological, clinical and population relevance of 95 loci for blood lipids | Q24622541 | ||
| Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 | ||
| Histone H3K27ac separates active from poised enhancers and predicts developmental state | Q24628758 | ||
| Hundreds of variants clustered in genomic loci and biological pathways affect human height | Q24630979 | ||
| From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus | Q24633183 | ||
| Combinatorial patterns of histone acetylations and methylations in the human genome | Q24647290 | ||
| High-resolution profiling of histone methylations in the human genome | Q27860906 | ||
| Chromatin modifications and their function | Q27861067 | ||
| Molecular genetics of the LDL receptor gene in familial hypercholesterolemia | Q28207758 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| High-resolution mapping and characterization of open chromatin across the genome | Q28266995 | ||
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | Q28270700 | ||
| Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes | Q28272915 | ||
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci | Q28281906 | ||
| A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese | Q28943551 | ||
| Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases | Q29417103 | ||
| Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci | Q29417126 | ||
| Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians | Q29417142 | ||
| Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 | Q29417143 | ||
| Mapping and analysis of chromatin state dynamics in nine human cell types | Q29547552 | ||
| Genomic maps and comparative analysis of histone modifications in human and mouse | Q29614418 | ||
| HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 | ||
| Evolving concepts of rheumatoid arthritis | Q29618020 | ||
| The NIH Roadmap Epigenomics Mapping Consortium | Q29619856 | ||
| High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis | Q30419111 | ||
| Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci | Q30425020 | ||
| The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings | Q33206291 | ||
| Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations | Q33549716 | ||
| Identification of new genetic risk variants for type 2 diabetes | Q33700532 | ||
| Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes | Q33904459 | ||
| Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA | Q33987569 | ||
| Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity | Q34027627 | ||
| Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation | Q34058172 | ||
| Mast cells: a cellular link between autoantibodies and inflammatory arthritis | Q34148153 | ||
| Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles | Q34263565 | ||
| Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus | Q35012624 | ||
| Dynamics of insulin secretion and the clinical implications for obesity and diabetes | Q35015726 | ||
| H3K4 tri-methylation provides an epigenetic signature of active enhancers | Q35422275 | ||
| Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 | ||
| DNase I sensitivity QTLs are a major determinant of human expression variation | Q36408973 | ||
| The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery | Q36743559 | ||
| Parental origin of sequence variants associated with complex diseases | Q37102209 | ||
| Functional enhancers at the gene-poor 8q24 cancer-linked locus. | Q37279616 | ||
| Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease | Q37318174 | ||
| The Plasma Lipoproteins: Structure and Metabolism | Q37802822 | ||
| Enhancers: mechanisms of action and cell specificity | Q39293275 | ||
| Common polymorphic transcript variation in human disease | Q40005558 | ||
| Functional and anatomical aspects of prefrontal pathology in schizophrenia | Q41609625 | ||
| Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging | Q48192520 | ||
| A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B | Q57249678 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | complex trait | Q55608248 |
| P304 | page(s) | 124-130 | |
| P577 | publication date | 2012-12-23 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Chromatin marks identify critical cell types for fine mapping complex trait variants | |
| P478 | volume | 45 |
| Q91938966 | A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis |
| Q34242043 | A comparison of control samples for ChIP-seq of histone modifications |
| Q37432574 | A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects |
| Q56451740 | A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus |
| Q92639275 | A practical view of fine-mapping and gene prioritization in the post-genome-wide association era |
| Q34632245 | A role for noncoding variation in schizophrenia |
| Q36515609 | A spectral approach integrating functional genomic annotations for coding and noncoding variants |
| Q36582277 | A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology |
| Q47365066 | Abnormal B-cell development in Systemic Lupus Erythematosus: what the genetics tell us. |
| Q36240287 | Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics Cell Types and Tissues by GenoSTAN. |
| Q38194867 | Advances in IBD genetics |
| Q34464114 | Advances in lupus genetics and epigenetics |
| Q89748473 | Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci |
| Q33727146 | Allele-specific methylation occurs at genetic variants associated with complex disease |
| Q33558410 | Allele-specific quantitative proteomics unravels molecular mechanisms modulated by cis-regulatory PPARG locus variation |
| Q30322686 | An Expanded View of Complex Traits: From Polygenic to Omnigenic |
| Q35086233 | An epidemiological perspective of personalized medicine: the Estonian experience |
| Q90600031 | Annotations capturing cell-type-specific TF binding explain a large fraction of disease heritability |
| Q34624885 | Approaches for establishing the function of regulatory genetic variants involved in disease |
| Q64056497 | Association analyses identify 31 new risk loci for colorectal cancer susceptibility |
| Q38781370 | Association of CD8(+) T-cells with bone erosion in patients with rheumatoid arthritis |
| Q27345314 | Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals |
| Q36257320 | Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? |
| Q26767040 | Autoimmune diseases - connecting risk alleles with molecular traits of the immune system |
| Q47874535 | Beyond genome-wide significance: integrative approaches to the interpretation and extension of GWAS findings for alcohol use disorder. |
| Q49376742 | CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis: Implications for Causal Gene Identification. |
| Q28109583 | Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23 |
| Q104134943 | Cerebral small vessel disease genomics and its implications across the lifespan |
| Q102059043 | Characterisation of CD4+ T-cell subtypes using single cell RNA sequencing and the impact of cell number and sequencing depth |
| Q35956999 | Characterization of genome-wide H3K27ac profiles reveals a distinct PM2.5-associated histone modification signature. |
| Q90243369 | Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases |
| Q34377776 | Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants |
| Q42770081 | Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits |
| Q47707412 | Comprehensive evaluation of disease- and trait-specific enrichment for eight functional elements among GWAS-identified variants |
| Q41380870 | Constraints on eQTL Fine Mapping in the Presence of Multisite Local Regulation of Gene Expression |
| Q47700292 | Context-specific effects of genetic variants associated with autoimmune disease |
| Q38259526 | Current trend of annotating single nucleotide variation in humans--A case study on SNVrap |
| Q38844237 | Decoding transcriptional enhancers: Evolving from annotation to functional interpretation |
| Q91786451 | Deconstructing and targeting the genomic architecture of human neurodegeneration |
| Q38993206 | Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and Mice |
| Q22066251 | Defining functional DNA elements in the human genome |
| Q39707845 | Defining the identity of mouse embryonic dermal fibroblasts |
| Q30407889 | Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis |
| Q38247072 | Detecting epistasis in human complex traits |
| Q88538387 | Detecting epistasis within chromatin regulatory circuitry reveals CAND2 as a novel susceptibility gene for obesity |
| Q60683708 | Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk |
| Q95325042 | Determinants of transcription factor regulatory range |
| Q53399539 | Diabetes in the post-GWAS era. |
| Q28834473 | Discovery and validation of sub-threshold genome-wide association study loci using epigenomic signatures |
| Q92578476 | Disease Heritability Enrichment of Regulatory Elements Is Concentrated in Elements with Ancient Sequence Age and Conserved Function across Species |
| Q42033919 | Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci. |
| Q62477903 | Disentangling the genetics of lean mass |
| Q35824036 | Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease. |
| Q30241340 | Dissecting the genetics of complex traits using summary association statistics |
| Q35203861 | Divergence and selectivity of expression-coupled histone modifications in budding yeasts |
| Q46069869 | Editorial: entering the age of whole-exome sequencing in rheumatic diseases: novel insights into disease pathogenicity |
| Q38797638 | Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis. |
| Q42366787 | Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease |
| Q38193691 | Enhancer biology and enhanceropathies |
| Q34624842 | Enhancer variants: evaluating functions in common disease |
| Q47597915 | Enhancers looping to target genes |
| Q38432390 | Epigenetic and gene expression analysis of ankylosing spondylitis-associated loci implicate immune cells and the gut in the disease pathogenesis |
| Q37446658 | Epigenetics in adipose tissue, obesity, weight loss, and diabetes |
| Q35945258 | Epigenomics in translational research |
| Q38365224 | Eukaryotic enhancers: common features, regulation, and participation in diseases |
| Q35787851 | Evaluating the Performance of Fine-Mapping Strategies at Common Variant GWAS Loci |
| Q99564808 | Evaluating the informativeness of deep learning annotations for human complex diseases |
| Q36264669 | Explaining additional genetic variation in complex traits |
| Q37336903 | Explaining the disease phenotype of intergenic SNP through predicted long range regulation |
| Q26825066 | Exploiting genomics and natural genetic variation to decode macrophage enhancers |
| Q37708629 | Expression quantitative trait analyses to identify causal genetic variants for type 2 diabetes susceptibility |
| Q40462197 | Extensive Association of Common Disease Variants with Regulatory Sequence. |
| Q37146808 | Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3. |
| Q56876835 | Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes |
| Q38704623 | Fine-mapping inflammatory bowel disease loci to single-variant resolution |
| Q37018494 | Fishing for Function in the Human Gene Pool |
| Q37027646 | From GWAS to function: lessons from blood cells. |
| Q88911128 | From genome-wide associations to candidate causal variants by statistical fine-mapping |
| Q38233759 | From the era of genome analysis to the era of genomic drug discovery: a pioneering example of rheumatoid arthritis |
| Q40273307 | Functional Architectures of Local and Distal Regulation of Gene Expression in Multiple Human Tissues. |
| Q57295531 | Functional architecture of low-frequency variants highlights strength of negative selection across coding and non-coding annotations |
| Q93161870 | Functional disease architectures reveal unique biological role of transposable elements |
| Q41779186 | Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis |
| Q38843497 | Functional interpretation of non-coding sequence variation: concepts and challenges |
| Q90618574 | Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease |
| Q85765348 | Functional relevance for multiple sclerosis-associated genetic variants |
| Q102075603 | Functionally informed fine-mapping and polygenic localization of complex trait heritability |
| Q42290203 | GARLIC: a bioinformatic toolkit for aetiologically connecting diseases and cell type-specific regulatory maps |
| Q28610484 | GREGOR: evaluating global enrichment of trait-associated variants in epigenomic features using a systematic, data-driven approach |
| Q91044925 | GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways |
| Q24289119 | GWAS of 126,559 individuals identifies genetic variants associated with educational attainment |
| Q36954041 | GWAS3D: Detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications |
| Q55474442 | GWAS4D: multidimensional analysis of context-specific regulatory variant for human complex diseases and traits. |
| Q37372402 | Gene expression elucidates functional impact of polygenic risk for schizophrenia |
| Q28650479 | Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease |
| Q91732560 | Genes with High Network Connectivity Are Enriched for Disease Heritability |
| Q28649603 | Genetic and epigenetic fine mapping of causal autoimmune disease variants |
| Q30278461 | Genetic and epigenetic variation in the lineage specification of regulatory T cells |
| Q38439633 | Genetic architectures of seropositive and seronegative rheumatic diseases |
| Q30277642 | Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function |
| Q92963829 | Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues |
| Q35836108 | Genetic basis of autoimmunity |
| Q60937379 | Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology |
| Q34076355 | Genetic determinants of P wave duration and PR segment |
| Q34501150 | Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci |
| Q38126785 | Genetic insights into common pathways and complex relationships among immune-mediated diseases |
| Q47717598 | Genetic insights into the neurodevelopmental origins of schizophrenia |
| Q37682430 | Genetic regulatory signatures underlying islet gene expression and type 2 diabetes |
| Q36277126 | Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease. |
| Q64106861 | Genetic variants differentially associated with rheumatoid arthritis and systemic lupus erythematosus reveal the disease-specific biology |
| Q38726782 | Genetics of autoimmune diseases: perspectives from genome-wide association studies |
| Q48254133 | Genetics of immune-mediated inflammatory diseases |
| Q29417000 | Genetics of rheumatoid arthritis contributes to biology and drug discovery |
| Q38350726 | Genetics of rheumatoid arthritis in Asia--present and future |
| Q33841329 | Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. |
| Q34108958 | Genetics, genomics, and their relevance to pathology and therapy |
| Q40047877 | Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. |
| Q59795648 | Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma |
| Q47557957 | Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels |
| Q91826392 | Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci |
| Q45821536 | Genome-wide mapping of genetic determinants influencing DNA methylation and gene expression in human hippocampus |
| Q29417007 | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility |
| Q38447734 | GenomeRunner web server: regulatory similarity and differences define the functional impact of SNP sets |
| Q92555547 | Genomic Analysis in the Age of Human Genome Sequencing |
| Q35864995 | Genomic modulators of gene expression in human neutrophils |
| Q102323876 | Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation |
| Q39155009 | Genomics of Islet (Dys)function and Type 2 Diabetes |
| Q52720499 | Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. |
| Q43086689 | High-Resolution Genetic Maps Identify Multiple Type 2 Diabetes Loci at Regulatory Hotspots in African Americans and Europeans |
| Q55249119 | High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing. |
| Q64110691 | IMPACT: Genomic Annotation of Cell-State-Specific Regulatory Elements Inferred from the Epigenome of Bound Transcription Factors |
| Q30417517 | Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci |
| Q31115470 | Identifying Liver Cancer-Related Enhancer SNPs by Integrating GWAS and Histone Modification ChIP-seq Data. |
| Q26800688 | Identifying a novel locus for psoriatic arthritis |
| Q47555364 | Identifying and exploiting trait-relevant tissues with multiple functional annotations in genome-wide association studies |
| Q34883568 | Identifying causal regulatory SNPs in ChIP-seq enhancers |
| Q36236807 | Immunogenetics of systemic lupus erythematosus: A comprehensive review |
| Q39441424 | Immunogenomic approaches to understand the function of immune disease variants |
| Q38994015 | Impact of autoimmune risk alleles on the immune system |
| Q104111130 | Improving the informativeness of Mendelian disease-derived pathogenicity scores for common disease |
| Q47377830 | Inferring Relevant Cell Types for Complex Traits by Using Single-Cell Gene Expression |
| Q64994676 | Integrated Functional Genomic Analysis Enables Annotation of Kidney Genome-Wide Association Study Loci. |
| Q30865659 | Integrating functional data to prioritize causal variants in statistical fine-mapping studies |
| Q34493813 | Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression |
| Q58587095 | Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity |
| Q35092644 | Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene |
| Q55346354 | Integrative Bioinformatics Approaches for Identification of Drug Targets in Hypertension. |
| Q38689233 | Integrative Genetic and Epigenetic Analysis Uncovers Regulatory Mechanisms of Autoimmune Disease |
| Q29615565 | Integrative analysis of 111 reference human epigenomes |
| Q91735356 | Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene |
| Q36860748 | Integrative genomic deconvolution of rheumatoid arthritis GWAS loci into gene and cell type associations. |
| Q35611443 | Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targets |
| Q46108278 | Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain. |
| Q64054868 | Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in Systemic Lupus Erythematosus |
| Q51092697 | Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis. |
| Q37336953 | Joint Bayesian inference of risk variants and tissue-specific epigenomic enrichments across multiple complex human diseases |
| Q30794057 | Joint analysis of functional genomic data and genome-wide association studies of 18 human traits |
| Q90391378 | Landscape of stimulation-responsive chromatin across diverse human immune cells |
| Q40115913 | Large meta-analysis of genome-wide association studies identifies five loci for lean body mass |
| Q38712554 | Large-Scale trans-eQTLs Affect Hundreds of Transcripts and Mediate Patterns of Transcriptional Co-regulation |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q30981389 | Leveraging Functional-Annotation Data in Trans-ethnic Fine-Mapping Studies |
| Q35903759 | Leveraging Genomic Annotations and Pleiotropic Enrichment for Improved Replication Rates in Schizophrenia GWAS. |
| Q42293260 | Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types. |
| Q35250745 | Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding |
| Q46949332 | Local Genetic Correlation Gives Insights into the Shared Genetic Architecture of Complex Traits |
| Q56475859 | MMARGE: Motif Mutation Analysis for Regulatory Genomic Elements |
| Q38652238 | Mechanisms of Type 2 Diabetes Risk Loci |
| Q92491787 | Mechanisms of tissue and cell-type specificity in heritable traits and diseases |
| Q92526740 | Mechanistic Characterization of RASGRP1 Variants Identifies an hnRNP-K-Regulated Transcriptional Enhancer Contributing to SLE Susceptibility |
| Q40513382 | Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry |
| Q40467398 | Molecular genetic contributions to self-rated health. |
| Q89326887 | Molecular windows into the human brain for psychiatric disorders |
| Q99572134 | Multi-omics study for interpretation of genome-wide association study |
| Q50531000 | Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. |
| Q87928799 | Multiple sclerosis genetics |
| Q35110560 | Neuroepigenomics: Resources, Obstacles, and Opportunities |
| Q47949775 | New insights into the epigenetics of inflammatory rheumatic diseases. |
| Q30844089 | New statistical approaches exploit the polygenic architecture of schizophrenia--implications for the underlying neurobiology |
| Q36065325 | Non-coding genetic variants in human disease |
| Q36152676 | Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis |
| Q38882078 | Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci |
| Q99569164 | Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites |
| Q93122165 | PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease |
| Q57785574 | PINES: phenotype-informed tissue weighting improves prediction of pathogenic noncoding variants |
| Q34397259 | Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants |
| Q28598223 | Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression |
| Q36225291 | Partitioning heritability by functional annotation using genome-wide association summary statistics |
| Q34478075 | Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases |
| Q36293782 | Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells |
| Q37012919 | Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes |
| Q38758623 | Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis |
| Q35018126 | Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression |
| Q47210541 | Principles and methods of in-silico prioritization of non-coding regulatory variants |
| Q42698342 | Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease. |
| Q26772104 | Progress and promise in understanding the genetic basis of common diseases |
| Q38275663 | Promoter or enhancer, what's the difference? Deconstruction of established distinctions and presentation of a unifying model. |
| Q38217249 | Protein-protein interactions and genetic diseases: The interactome |
| Q37699035 | RETRACTED ARTICLE: Detection and replication of epistasis influencing transcription in humans |
| Q47143371 | Rare non-coding variants are associated with plasma lipid traits in a founder population |
| Q35110309 | Rare variant association studies: considerations, challenges and opportunities |
| Q39741892 | Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis. |
| Q30412060 | Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells |
| Q57059979 | Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease |
| Q48198050 | Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis. |
| Q39407376 | Review: Enhancers in Autoimmune Arthritis: Implications and Therapeutic Potential |
| Q87726283 | Rheumatoid arthritis |
| Q48153321 | Running spell-check to identify regulatory variants |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q91891499 | Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines |
| Q96127000 | Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism |
| Q38977818 | Strategies to fine-map genetic associations with lipid levels by combining epigenomic annotations and liver-specific transcription profiles |
| Q64883875 | Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis. |
| Q38662596 | Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease |
| Q40978989 | The Importance of Context: Uncovering Species- and Tissue-Specific Effects of Genetic Risk Variants for Type 2 Diabetes |
| Q26784416 | The complexity of epigenetic diseases |
| Q37297746 | The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals |
| Q39343367 | The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping |
| Q39029106 | The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting |
| Q64282374 | The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression |
| Q42361578 | The performance of a new local false discovery rate method on tests of association between coronary artery disease (CAD) and genome-wide genetic variants. |
| Q38364456 | The role of regulatory variation in complex traits and disease |
| Q28081960 | The selection and function of cell type-specific enhancers |
| Q49511487 | Thinking BIG rheumatology: how to make functional genomics data work for you. |
| Q35793648 | Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements |
| Q37140821 | Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases |
| Q91732423 | Trans Effects on Gene Expression Can Drive Omnigenic Inheritance |
| Q30276011 | Trans-ethnic Fine Mapping Highlights Kidney-Function Genes Linked to Salt Sensitivity |
| Q60921869 | Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies |
| Q35203515 | Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis |
| Q58462188 | Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights |
| Q40287055 | Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. |
| Q30390388 | Type 2 diabetes: genetic data sharing to advance complex disease research |
| Q36411544 | Uncovering the contribution of epigenetics to plant phenotypic variation in Mediterranean ecosystems. |
| Q38716873 | Understanding the genetic liability to schizophrenia through the neuroepigenome |
| Q92684595 | Unveiling the gene regulatory landscape in diseases through the identification of DNase I-hypersensitive sites |
| Q90419850 | Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond |
| Q38998159 | Update on the genetic architecture of rheumatoid arthritis |
| Q28544942 | Use of genome-wide association studies for cancer research and drug repositioning |
| Q38167223 | Using chromatin marks to interpret and localize genetic associations to complex human traits and diseases. |
| Q26865379 | Using the ENCODE Resource for Functional Annotation of Genetic Variants |
| Q38122628 | Validating therapeutic targets through human genetics |
| Q34455951 | What are super-enhancers? |
| Q35930706 | Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding? |
| Q37694098 | Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom |
| Q37708369 | cepip: context-dependent epigenomic weighting for prioritization of regulatory variants and disease-associated genes |
Search more.